mutated isocitrate dehydrogenase 1 (IDH1) inhibitor

mutated isocitrate dehydrogenase 1 (IDH1) inhibitor
Trade Name
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2017-04-27 00:00:00
Sponsor FORMA Therapeutics, Inc.;500 Arsenal Street, Suite 100;Watertown, Massachusetts, 02472
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia